AI assistant
Sending…
Cigna Group — Director's Dealing 2023
Feb 25, 2023
29918_dirs_2023-02-24_40791956-d45c-44be-b97a-00a92d4fc681.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Cigna Group (CI)
CIK: 0001739940
Period of Report: 2023-02-22
Reporting Person: Palmer Eric P (President & CEO, Evernorth)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2023-02-22 | Common Stock, $.01 Par Value | A | 5304.0000 | $0.0000 | Acquired | 42142.0000 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-02-22 | Employee Stock Option (Right to Buy) | $294.6100 | A | 19600.0000 | Acquired | 2033-02-22 | Common Stock, $.01 Par Value (19600.0000) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock, $.01 Par Value | 240.6184 | Indirect |
| Common Stock, $.01 Par Value | 40.4065 | Indirect |
| Common Stock, $.01 Par Value | 735.0000 | Indirect |
Footnotes
F1: These restricted shares vest in three equal annual installments beginning March 1, 2024.
F2: Represents shares acquired through ongoing participation in Cigna's 401(k) Plan.
F3: This option vests in three equal annual installments beginning March 1, 2024.
More from Cigna Group
Regulatory Filings
2026
May 13
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4
Director's Dealing
2026
Mar 4